The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

Hims & Hers Health (NYSE: HIMS) experienced a notable uptick in its stock price following the announcement of its planned ...

It was 2006 when Dr. Daniel Gibbs first noticed he was losing his sense of smell. But it wasn't what he didn't smell that ...

U.S. FDA Approves NUBEQA® (darolutamide) to Treat Patients with Metastatic Castration-Sensitive Prostate Cancer ...

Health Secretary Robert F. Kennedy Jr. has directed the Food and Drug Administration to review the nutrients and other ...

FDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (MCD) Test ...

While the Rocket Classic is fast approaching, it's already seeing some big news with a new name, a new trophy, and some ...

Lyra Therapeutics stock surged in premarket trading after announcing positive Phase 3 trial results for a key treatment.

HB 8 bans the distribution of tobacco, tobacco products, electronic nicotine delivery systems, and e-liquids through vending ...

Pomerantz LLP is investigating claims on behalf of investors of  Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") . Such investors are advised to contact Danielle Peyton at ...

Research news last week included Rocket Pharmaceuticals suffering a setback with its Phase II trial of RP-A501, which ...